No Level 4 Travel Health Notice has been issued in 2026, as no disease outbreak currently meets the CDC’s criteria for extreme risk where no effective precautions exist. The most recent development, a May 2026 Level 3 notice for Ebola (Bundibugyo virus) in the Democratic Republic of the Congo and Uganda, reflects contained transmission under official monitoring rather than uncontrolled spread. Lower-tier alerts for dengue, malaria, and diphtheria remain geographically limited with stable case trends. Historical precedent shows Level 4 notices require exceptional conditions like novel pathogens without countermeasures or widespread infrastructure collapse, none of which align with current surveillance data through early June.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেডCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,848 Vol.
$71,848 Vol.
Dec 31, 2026
$71,848 Vol.
$71,848 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 Travel Health Notice has been issued in 2026, as no disease outbreak currently meets the CDC’s criteria for extreme risk where no effective precautions exist. The most recent development, a May 2026 Level 3 notice for Ebola (Bundibugyo virus) in the Democratic Republic of the Congo and Uganda, reflects contained transmission under official monitoring rather than uncontrolled spread. Lower-tier alerts for dengue, malaria, and diphtheria remain geographically limited with stable case trends. Historical precedent shows Level 4 notices require exceptional conditions like novel pathogens without countermeasures or widespread infrastructure collapse, none of which align with current surveillance data through early June.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
মার্কেট ওপেন হয়েছে: Jan 19, 2026, 3:15 PM ET
ভলিউম
$71,848শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.No Level 4 Travel Health Notice has been issued in 2026, as no disease outbreak currently meets the CDC’s criteria for extreme risk where no effective precautions exist. The most recent development, a May 2026 Level 3 notice for Ebola (Bundibugyo virus) in the Democratic Republic of the Congo and Uganda, reflects contained transmission under official monitoring rather than uncontrolled spread. Lower-tier alerts for dengue, malaria, and diphtheria remain geographically limited with stable case trends. Historical precedent shows Level 4 notices require exceptional conditions like novel pathogens without countermeasures or widespread infrastructure collapse, none of which align with current surveillance data through early June.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ভলিউম
$71,848শেষ তারিখ
Dec 31, 2026মার্কেট ওপেন হয়েছে
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...No Level 4 Travel Health Notice has been issued in 2026, as no disease outbreak currently meets the CDC’s criteria for extreme risk where no effective precautions exist. The most recent development, a May 2026 Level 3 notice for Ebola (Bundibugyo virus) in the Democratic Republic of the Congo and Uganda, reflects contained transmission under official monitoring rather than uncontrolled spread. Lower-tier alerts for dengue, malaria, and diphtheria remain geographically limited with stable case trends. Historical precedent shows Level 4 notices require exceptional conditions like novel pathogens without countermeasures or widespread infrastructure collapse, none of which align with current surveillance data through early June.
Polymarket ডেটা রেফারেন্স করে পরীক্ষামূলক AI-জেনারেটেড সারাংশ। এটি ট্রেডিং পরামর্শ নয় এবং এই মার্কেট কীভাবে রেজলভ হয় তাতে কোনো ভূমিকা রাখে না। · আপডেটেড
বাহ্যিক লিংক থেকে সাবধান।
বাহ্যিক লিংক থেকে সাবধান।
সচরাচর জিজ্ঞাসা